Single administration of resveratrol improves social behavior in adult mouse models of autism spectrum disorder

References

• Park HR, Lee JM, Moon HE, et al. A short review on the current understanding of autism spectrum disorders. Exp Neurobiol. 2016;1:1–13.
   Google Scholar
• Tordjman S, Somogyi E, Coulon N, et al. Gene × environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front Psychiatry. 2014;5:53.
   PubMed Web of Science ®Google Scholar
• Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ. 2018;67:1–23.
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493–506.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Liu B, Zhou Z. Resveratrol activates SIRT1 in a Lamin A-dependent manner. Cell Cycle. 2013;12:872–876.
   PubMed Web of Science ®Google Scholar
• Olas B, Wachowicz B, Majsterek I, et al. Resveratrol may reduce oxidative stress induced by platinum compounds in human plasma, blood platelets and lymphocytes. Anticancer Drugs. 2005;16:659–665.
   PubMed Web of Science ®Google Scholar
• de Sá Coutinho D, Pacheco MT, Frozza RL, et al. Anti-inflammatory effects of resveratrol: mechanistic insights. Int J Mol Sci. 2018;19(6):E1812.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang CX, Liu YM, et al. A comparative study of anti-aging properties and mechanism: resveratrol and caloric restriction. Oncotarget. 2017;8:65717–65729.
   PubMedGoogle Scholar
• Carter LG, D’Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014;21:R209–225.
   PubMed Web of Science ®Google Scholar
• Wu JM, Hsieh TC, Wang Z. Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues. Am J Cardiovasc Dis. 2011;1:38–47.
   PubMedGoogle Scholar
• Guo Z, Liu Y, Cheng M. Resveratrol protects bupivacaine-induced neuro-apoptosis in dorsal root ganglion neurons via activation on tropomyosin receptor kinase A. Biomed Pharmacother. 2018;103:1545–1551.
   PubMed Web of Science ®Google Scholar
• Li YC, Liu YM, Shen JD, et al. Resveratrol ameliorates the depressive-like behaviors and metabolic abnormalities induced by chronic corticosterone injection. Molecules. 2016;21:10. DOI:10.3390/molecules21101341
   Web of Science ®Google Scholar
• Bambini-Junior V, Zanatta G, Della Flora Nunes G, et al. Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neurosci Lett. 2014;583:176–181.
   PubMed Web of Science ®Google Scholar
• Andrade S, Ramalho MJ, Pereira MDC, et al. Resveratrol brain delivery for neurological disorders prevention and treatment. Front Pharmacol. 2018. DOI:10.3389/fphar.2018.01261
   Web of Science ®Google Scholar
• Takayanagi Y, Yoshida M, Bielsky IF, et al. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci U S A. 2005;102:16096–16101.
   PubMed Web of Science ®Google Scholar
• Slane MM, Lusk LG, Boomer KB, et al. Social cognition, face processing, and oxytocin receptor single nucleotide polymorphisms in typically developing children. Dev Cogn Neurosci. 2014;9:160–171.
   PubMed Web of Science ®Google Scholar
• Yatawara CJ, Einfeld SL, Hickie IB, et al. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry. 2016;21:1225–1231.
   PubMed Web of Science ®Google Scholar
• Guastella AJ, Gray KM, Rinehart NJ, et al. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol. 2015;56:444–452.
   Google Scholar
• Dai YC, Zhang HF, Schön M, et al. Neonatal oxytocin treatment ameliorates autistic-like behaviors and oxytocin deficiency in valproic acid-induced rat model of autism. Front Cell Neurosci. 2018;12:355.
   PubMed Web of Science ®Google Scholar
• Hara Y, Ago Y, Higuchi M, et al. Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism. Horm Behav. 2017;96:130–136.
   PubMed Web of Science ®Google Scholar
• Nadler JJ, Moy SS, Dold G, et al. Automated apparatus for quantitation of social approach behaviours in mice. Genes Brain Behav. 2004;3(5):303–314.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Hiraoka Y, Hidema S, et al. Prenatal minocycline treatment alters synaptic protein expression, and rescues reduced mother call rate in oxytocin receptor-knockout mice. Biochem Biophys Res Commun. 2016;472:319–323.
   PubMed Web of Science ®Google Scholar
• Zhang S, Gao L, Liu X, et al. Resveratrol attenuates microglial activation via SIRT1-SOCS1 pathway. Evid Based Complement Alternat Med. 2017;2017:1–10.
   Web of Science ®Google Scholar
• Chandra R, Francis TC, Konkalmatt P, et al. Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action. J Neurosci. 2015;35:7927–7937.
   PubMed Web of Science ®Google Scholar
• Mizutani N, Omori Y, Kawamoto Y, et al. Resveratrol-induced transcriptional up-regulation of ASMase (SMPD1) of human leukemia and cancer cells. Biochem Biophys Res Commun. 2016;470:851–856.
   PubMed Web of Science ®Google Scholar
• Xie YK, Zhou X, Yuan HT, et al. Resveratrol reduces brain injury after subarachnoid hemorrhage by inhibiting oxidative stress and endoplasmic reticulum stress. Neural Regen Res. 2019;14:1734–1742.
   PubMed Web of Science ®Google Scholar
• Dou Z, Rong X, Zhao E, et al. Neuroprotection of resveratrol against focal cerebral ischemia/reperfusion injury in mice through a mechanism targeting gut-brain axis. Cell Mol Neurobiol. 2019;39:883–898.
   PubMed Web of Science ®Google Scholar
• Michan S, Li Y, Chou MM-H, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci. 2010;30:9695–9707.
   PubMed Web of Science ®Google Scholar
• Bhandari R, Paliwal JK, Kuhad A. Dietary phytochemicals as neurotherapeutics for autism spectrum disorder: plausible mechanism and evidence. Adv Neurobiol. 2020;24:615–646.
   PubMedGoogle Scholar
• Xu L, Xu S, Lin L, et al. High-fat diet mediates anxiolytic-like behaviors in a time-dependent manner through the regulation of SIRT1 in the brain. Neuroscience. 2018;21:237–245.
   Google Scholar
• Takayanagi Y, Kasahara Y, Onaka T, et al. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport. 2008;19:951–955.
   PubMed Web of Science ®Google Scholar
• Ornoy A, Weinstein-Fudim L, Ergaz Z. Prevention or amelioration of autism-like symptoms in animal models: will it bring us closer to treating human ASD? Int J Mol Sci. 2019;20(5):1074.
   Web of Science ®Google Scholar
• Ingram JL, Peckham SM, Tisdale B, et al. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol. 2000;22(3):319–324.
   PubMed Web of Science ®Google Scholar
• Fontes-Dutra M, Santos-Terra J, Deckmann I, et al. Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid. Front Synaptic Neurosci. 2018;10:9.
   PubMed Web of Science ®Google Scholar
• Al-Amin MM, Rahman MM, Khan FR, et al. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav Brain Res. 2015;286:112–121.
   PubMed Web of Science ®Google Scholar
• Pragnya B, Kameshwari JS, Veeresh B. Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice. Behav Brain Res. 2014;270:86–94.
   PubMed Web of Science ®Google Scholar
• Blume A, Bosch OJ, Miklos S, et al. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci. 2008;27(8):1947–1956.
   PubMed Web of Science ®Google Scholar
• Mustafi SB, Chakraborty PK, Raha S. Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70. PLoS One. 2010;5(1):e8719.
   PubMed Web of Science ®Google Scholar
• Wang X, Xie Y, Zhang T, et al. Resveratrol reverses chronic restraint stress-induced depression-like behaviour: involvement of BDNF level, ERK phosphorylation and expression of Bcl-2 and Bax in rats. Brain Res Bull. 2016;125:134–143.
   PubMed Web of Science ®Google Scholar
• Ferguson JN, Aldag JM, Insel TR, et al. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci. 2001;21:8278–8285.
   PubMed Web of Science ®Google Scholar
• Bertelsen F, Folloni D, Møller A, et al. Suppressed play behaviour and decreased oxytocin receptor binding in the amygdala after prenatal exposure to low-dose valproic acid. Behav Pharmacol. 2017;28:450–457.
   PubMed Web of Science ®Google Scholar